Further, glial fibrillary acidic protein (GFAP) is also associated with brain Aβ pathology as a potential early marker of AD pathogenesis in plasma [83], expression of GFAP in hippocampus is associated with AD pathogenesis [84] and increased transcription levels of GFAP is associated with AD progression [85]. Here, GFAP is linked to Alzheimer disease.